Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 12, Issue 7 (2023)

Polycystic ovary syndrome (multifactorial endocrinopathy): manifestation and treatment strategies

Author(s):
Gurleen Kaur Panesar and Aparajita Bhasin
Abstract:
Polycystic ovary syndrome is a disorder featuring poor ovarian health and hormonal imbalance as its primary characteristics. This disorder disturbs the three basic aspects of life - physical, mental, and social health due to the changes in the normal functioning of organs and depression associated with low self-esteem. However, detection of this syndrome is a difficult task due to its common symptoms and hence must be excluded from the disorders with similar manifestations like idiopathic hyperandrogenism and diabetes. It is a multifactorial endocrinopathy, and a single symptom is having the potential to lead to other health issues. Whereas, high amounts of androgens consequently lead to hirsutism, disordered folliculogenesis, and dyslipidemia. Infertility, an additional health issue associated with polycystic ovary syndrome commonly found in females these days is also linked to poor lifestyle habits like less exercise and diets rich in fat and sugar. Although, various treatments including chemical drugs and herbal therapies aid in curing hormonal imbalances. However, trust towards the utility of herbs is still a preferred option due to fewer side effects and easy availability in the locality. A few chemical drugs like bicalutamide and flutamide impart an anti-androgenic effect on the body to cure the syndrome but also have a bad effect on liver health. The present review of literature puts forward information about polycystic ovary syndrome and its clinical manifestations, along with the management of the syndrome.
Pages: 2561-2567  |  412 Views  282 Downloads


The Pharma Innovation Journal
How to cite this article:
Gurleen Kaur Panesar, Aparajita Bhasin. Polycystic ovary syndrome (multifactorial endocrinopathy): manifestation and treatment strategies. Pharma Innovation 2023;12(7):2561-2567. DOI: 10.22271/tpi.2023.v12.i7ad.21644

Call for book chapter